(19)
(11) EP 4 815 946 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898743.0

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/4245(2006.01)
A61P 31/04(2006.01)
A61K 31/37(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/4245; A61K 31/37; A61P 31/04
(86) International application number:
PCT/US2024/057701
(87) International publication number:
WO 2025/117707 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.12.2023 US 202363605156 P

(71) Applicant: The Children's Medical Center Corporation
Boston, MA 02115 (US)

(72) Inventors:
  • SCHAEFERS, Matthew M.
    Boston, Massachusetts 02115 (US)
  • PRIEBE, Gregory P.
    Boston, Massachusetts 02115 (US)

(74) Representative: Simmons & Simmons LLP (Munich) 
Lehel Carré Gewürzmühlstraße 11
80538 Munich
80538 Munich (DE)

   


(54) ANTI-VIRULENCE AGENTS AND METHODS FOR THE TREATMENT OF PATHOGENIC BACTERIUM